Skip to content

A Trial Comparing - Robotic Assisted Versus Laparoscopic Partial Nephrectomy For Small Renal Masses

A Prospective Randomized Controlled Trial Comparing Two Minimally Invasive Surgical Modalities - Robotic Assisted Vs. Pure Laparoscopic Partial Nephrectomy For Small Renal Masses.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02933398
Acronym
RALPLPNNX
Enrollment
104
Registered
2016-10-14
Start date
2021-12-31
Completion date
2022-12-31
Last updated
2021-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Renal Masses

Brief summary

A prospective, randomized, controlled trial including patients who are diagnosed with a small renal mass (\<4 cm) amenable to resection using either RALPN or LPN.

Detailed description

Small renal masses (SRM) \<4cm are increasingly being discovered incidentally on imaging. The standard of care for management of SRMs is partial nephrectomy whenever feasible. In the last 10 years, a minimally invasive laproscopic approach has largely supplanted open surgery for the treatment of SRMs. Robot-assisted laparoscopic partial nephrectomy (RALPN) has emerged as an alternative to laparoscopic partial nephrectomy (LPN) and has been able to bridge the technical difficulties of LPN. The big question about the role and cost of RALPN in comparison to LPN especially in Canadian healthcare for SRMs still remains unanswered. The objective of this proposed study is to conduct a randomized controlled trial to determine whether RALPN is better than LPN for the management of patients with SRMs. The primary outcomes will be warm ischemia time and secondary outcomes will be estimated glomerular filtration rate (eGFR), estimated blood loss, complication rate, length of hospital stay, positive surgical margin rate and cost comparison of these two techniques.

Interventions

PROCEDURERobotic Assisted Nephrectomy

Robotic (Davinci)

PROCEDURELaparoscopic Assisted Nephrectomy

Regular Laparoscopic Technique.

Sponsors

St. Joseph's Healthcare Hamilton
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients at least 18 years of age and capable of giving informed consent 2. Patients scheduled for treatment of a renal tumor suitable to undergo LPN /RALPN 3. Patients with SRMs (tumor(s) ≤ 4 cm)

Exclusion criteria

1. Large tumors \> 4.0cm 2. Unable to have a general anesthetic 3. Unable to comply with post-operative follow-up protocol 4. Uncorrectable bleeding diathesis 5. Tumors unsuitable for LPN/RALPN technique 6. Evidence of metastatic disease 7. Prior surgery on the affected kidney 8. Ectopic or malrotated kidney 9. Mental health condition that precludes informed consent

Design outcomes

Primary

MeasureTime frameDescription
Warm ischemia timeDuration of the Surgical Procedure (Nephrectomy)It will be measured intraoperatively from the time of application of Satinsky clamp on the renal hilum to the release of clamp (in minutes).

Secondary

MeasureTime frameDescription
Estimated blood lossDuration of the Surgical Procedure (Nephrectomy)Will be measured intraoperatively from the amount of blood (ml) in the suction container.
Complication rates as per Clavien-Dindo classificationUp to 24 months post-operatively.It will be recorded for the intra-operative, post-operative and follow-up period.
Conversion rate to radical nephrectomy or OPN due to technical difficulty.Duration of the Surgical ProcedureFrom the start of the partial nephrectomy in minutes to the time it was decided to convert to a radical nephrectomy.
eGFRUp to 24 months post operatively.It will be measured preoperatively, postoperatively and at each of the follow-up visit.
Length of hospital stay3-7 DaysCalculated from day of admission to day of discharge from hospital.
Positive surgical margin rate14 daysWill be based on the final pathology results which are usually ready in 1-2 weeks post surgery. Distance to surgical margin will be looked at (mm to cm).
Costs of treatmentUp to 1 yearClinical data and resource use for both treatments will be collected and unit cost estimates will be based on the St. Joseph Healthcare case-costing system. The cost will be conducted from the perspective of Ontario Ministry of Health and Long-term Care. The cost of hospital stay will be calculated along with any hospital stay/procedure associated with a post-op complication.
Postoperative painMinutes to hours after nephrectomy up to 3 months post-operatively.

Countries

Canada

Contacts

Primary ContactAnil Kapoor, MD, FRCSC
akapoor@mcmaster.ca905-522-1155
Backup ContactCamilla Tajzler, BA, CCRA
tajzlec@mcmaster.ca905-522-1155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026